• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: Bone-marrow responses in polycythemia vera.

作者信息

Prchal J F, Axelrad A A

出版信息

N Engl J Med. 1974 Jun 13;290(24):1382. doi: 10.1056/nejm197406132902419.

DOI:10.1056/nejm197406132902419
PMID:4827655
Abstract
摘要

相似文献

1
Letter: Bone-marrow responses in polycythemia vera.信函：真性红细胞增多症中的骨髓反应。
N Engl J Med. 1974 Jun 13;290(24):1382. doi: 10.1056/nejm197406132902419.
2
[Abnormal sensitivity to erythropoietin in the erythroblast precursors in Vaquez disease].[真性红细胞增多症中幼红细胞前体对促红细胞生成素的异常敏感性]
C R Acad Hebd Seances Acad Sci D. 1977 Jun 27;284(24):2589-92.
3
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.真性红细胞增多症。正常和异常干细胞系对促红细胞生成素的体外反应。
J Clin Invest. 1978 Apr;61(4):1044-7. doi: 10.1172/JCI109003.
4
Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.真性红细胞增多症骨髓体外红系集落形成。对促红细胞生成素的依赖性。
J Clin Invest. 1977 May;59(5):841-8. doi: 10.1172/JCI108706.
5
Application of the in vitro erythropoietin system to the study of human bone marrow disease: polycythemia vera.
Ann N Y Acad Sci. 1968 Mar 29;149(1):430-6. doi: 10.1111/j.1749-6632.1968.tb15179.x.
6
[In vitro study of erythroid precursors in Vaquez' disease (polycythemia vera). Evidence supporting 2 populations of erythroid stem cells in the bone marrow].
Nouv Rev Fr Hematol (1978). 1978;20(4):565-74.
7
[Studies of the pathogenesis of polycythemia vera with a special emphasis on the kinetics of hemopoietic stem cells (author's transl)].
Rinsho Ketsueki. 1974 Mar;15(3):237-42.
8
[Comparative morphofunctional characteristics of the erythroid cells in polycythemia vera and familial-hereditary erythrocytosis].真性红细胞增多症和家族遗传性红细胞增多症中红细胞系细胞的比较形态功能特征
Probl Gematol Pereliv Krovi. 1980 Jul;25(7):23-7.
9
Polycythemia vera and other polycythemic states.真性红细胞增多症和其他红细胞增多状态。
Clin Lab Med. 1990 Dec;10(4):857-71.
10
Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.小鼠和人骨髓培养中的红系集落形成：通过琼脂糖-伴刀豆球蛋白A凝胶过滤和亲和层析分析对促红细胞生成素的需求
J Cell Physiol. 1974 Apr;83(2):309-20. doi: 10.1002/jcp.1040830218.

引用本文的文献

1
Polycythaemia vera.真性红细胞增多症
Nat Rev Dis Primers. 2025 Apr 17;11(1):26. doi: 10.1038/s41572-025-00608-3.
2
Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey.血小板生成素，血小板生成的主要调节因子：从神话到理性，三十年的历程
Biomolecules. 2024 Apr 18;14(4):489. doi: 10.3390/biom14040489.
3
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.SRSF2 突变可减少红细胞增多症，并损害 JAK2V617F 驱动的骨髓增殖性肿瘤中的造血祖细胞功能。
Blood Cancer J. 2023 Nov 27;13(1):171. doi: 10.1038/s41408-023-00947-y.
4
Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms.JAK2V617F 体细胞突变导致骨髓增殖性肿瘤不同表型的潜在机制研究进展。
Int J Mol Sci. 2022 Jan 18;23(3):1013. doi: 10.3390/ijms23031013.
5
The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.LNK（SH2B3）在造血过程中对JAK-STAT信号通路的调控作用
Pharmaceuticals (Basel). 2021 Dec 24;15(1):24. doi: 10.3390/ph15010024.
6
NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients.NGS 评估伯尔尼队列不明原因红细胞增多症患者。
Genes (Basel). 2021 Dec 4;12(12):1951. doi: 10.3390/genes12121951.
7
Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models.单独或与鲁索替尼联合使用对胰岛素生长因子-1受体（IGF-1R）进行药理抑制在临床前骨髓增殖性肿瘤模型中显示出治疗效果。
Hemasphere. 2021 Apr 30;5(5):e565. doi: 10.1097/HS9.0000000000000565. eCollection 2021 May.
8
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.血小板生成素受体MPL是骨髓增殖性肿瘤中一个可利用的治疗靶点。
Front Oncol. 2021 Mar 10;11:641613. doi: 10.3389/fonc.2021.641613. eCollection 2021.
9
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy.真性红细胞增多症的新视角：从诊断到治疗。
Int J Mol Sci. 2020 Aug 13;21(16):5805. doi: 10.3390/ijms21165805.
10
Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera.血小板生成素对于 JAK2V617F 转基因小鼠模型真性红细胞增多症的完全表型表达是必需的。
PLoS One. 2020 Jun 1;15(6):e0232801. doi: 10.1371/journal.pone.0232801. eCollection 2020.